[Federal Register Volume 62, Number 133 (Friday, July 11, 1997)]
[Notices]
[Pages 37270-37271]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 97-18148]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

National Institutes of Health


National Institute of Child Health and Human Development; Notice 
of Meeting

    Pursuant to Section 10(d) of the Federal Advisory Committee Act, as 
amended (5 U.S.C. Appendix 2), notice is hereby given of the following 
National Institute of Child Health and Human Development Special 
Emphasis Panel (SEP) meeting:
    The meeting will be open to the public to provide concept review of 
proposed contract solicitations.
    Individuals who plan to attend and need special assistance, such a 
sign language interpretation or other reasonable accommodations, should 
inform the Contact Person listed below in advance of the meeting.


[[Page 37271]]


    Name of SEP: Development and Implementation of a Plan to Assess 
the Neurodevelopment of Infants and Children Exposed to Drug in 
utero (TELECONFERENCE).
    Date: July 29, 1997.
    Time: 2:00 p.m. (est)-adjournment.
    Place: 6100 Executive Boulevard, 6100 Building--Room 5E01, 
Rockville, Maryland 20852.
    Contact Person: Hameed Khan, Ph.D., Scientific Review 
Administrator, NICHD, 6100 Executive Boulevard, 6100 Building, Room 
5E01, Rockville, Maryland 20852, Telephone: 301-496-1485.
    Purpose: To provide concept review of proposed contract 
solicitations.

(Catalog of Federal Domestic Assistance Program Nos. [93.864, 
Population Research and No. 93.865, Research for Mothers and 
Children], National Institutes of Health)

    Dated: July 3, 1997.
LaVerne Y. Stringfield,
Committee Management Officer, NIH.
[FR Doc. 97-18148 Filed 7-10-97; 8:45 am]
BILLING CODE 4140-01-M